跳转至内容
Merck
CN

ABC940

Anti-SNX18 Antibody

from rabbit, purified by affinity chromatography

别名:

Sorting nexin-18, SH3 and PX domain-containing protein 3B, Sorting nexin-associated Golgi protein 1, SNX18

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ICC, IP, WB
Citations:
-
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

purified by

affinity chromatography

species reactivity

human, canine

technique(s)

immunocytochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Quality Level

Gene Information

human ... SNX18(112574)

General description

Sorting nexin-18 (UniProt Q96RF0; also known as SH3 and PX domain-containing protein 3B, Sorting nexin-associated Golgi protein 1) is encoded by the SNX18 (also known as SNAG1, SH3PX2, SH3PXD3B) gene (Gene ID 112574) in human. SNX18, SNX33, and SNX9 constitute a subfamily of sorting nexin (SNX) proteins characterized by a Bin–Amphiphysin–Rvs (BAR) domain that allows dimerization. It also contributes to modulation and shaping of membrane curvature. It also has a Src-homology 3 (SH3) domain that allows interaction with a wide range of proline-rich PXXP motif containing proteins. In addition to mediating endocytosis and intracellular vesicle trafficking, SNX18, SNX33, and SNX9 are also essential for successful completion of the ingression and abscission stages of cytokinesis and for the delivery of a subset of vesicles to the intracellular bridge that connects the two nascent daughter cells during mitosis. GSK‐3 is reported to prevent FIP5-SNX18 interaction during metaphase and anaphase in Madin‐Darby canine kidney (MDCK) cells by catalyzing FIP5 Thr276 phosphorylation to ensure the fidelity and timing of FIP5‐endosome targeting to the AMIS during apical lumen formation.
~73 kDa observed

Immunogen

Recombinant protein corresponding to human SNX18.

Application

Western Blotting Analysis: A representative lot detected endogenous SNX18 in MDCK and HeLa cell lysates (Willenborg, C., et al. (2011). J Cell Biol. 195(1):71-86).
Western Blotting Analysis: A representative lot detected endogenous SNX18 in MDCK cell lysates (Li, D., et al. (2014). EMBO J. 15(4):428-437).
Immunoprecipitation Analysis: A representative lot immunoprecipitated endogenous SNX18 in MDCK cell lysates (Willenborg, C., et al. (2011). J Cell Biol. 195(1):71-86).
Immunocytochemistry Analysis: A representative lot detected SNX18 in filter-grown, polarized MDCK cells, as well as polarized MDCK cells grown in 3D cultures (Willenborg, C., et al. (2011). J Cell Biol. 195(1):71-86).
Research Category
Apoptosis & Cancer
Research Sub Category
Apoptosis - Additional
This Anti-SNX18 Antibody is validated for use in Western Blotting, Immunoprecipitation, Immunocytochemistry for the detection of SNX18 .

Biochem/physiol Actions

Expected to react with all spliced isoforms.

Physical form

Affinity purified
Purified rabbit polyclonal antibody in PBS with 0.05% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of receipt.

Analysis Note

Evaluated by Western Blotting in MDCK cell lysate.

Western Blotting Analysis: 1.0 µg/mL of this antibody detected SNX18 in 10 µg of MDCK cell lysate.

Other Notes

Concentration: Please refer to lot specific datasheet.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

相关内容

A major focus of breast cancer research is to understand the mechanisms responsible for disease progression and drug resistance. Toward that end, it has been found that approximately two thirds of all human breast carcinomas overexpress the Estrogen Receptor α (ERα) protein and it remains the primary pharmacological target for endocrine therapy1,2. The normal cellular function of ERα is as a transcription factor that mediates a wide variety of physiological processes, many of which are dependent upon phosphorylation of the receptor at specific amino acid residues3,4. Indeed, ERα is known to be phosphorylated at a multitude of different sites, yet how these all correlate to disease remains unclear5. Here, we interrogated multiple sites of ERα for phosphorylation status by screening an extensive panel of different breast cancer patient samples and other non-breast cancer tissue microarray (TMA) slide samples to determine their relevance to disease.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持